Diverticulitis Terminated Phase 3 Trials for Mesalazine (DB00244)

Also known as: Diverticulitides / Diverticulitis NOS

IndicationStatusPhase
DBCOND0000210 (Diverticulitis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01038739Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of DiverticulitisPrevention
NCT00695643Mesalazine Granules vs. Placebo for the Prevention of Recurrence of DiverticulitisPrevention